Table 2.
The KEGG pathways enriched by the potential target genes of miR-542-5p
| ID | Description | Count in gene set | p-value |
|---|---|---|---|
| hsa05032 | Morphine addiction | 11 | 0.000111 |
| hsa04024 | cAMP signaling pathway | 15 | 0.000587 |
| hsa04261 | Adrenergic signaling in cardiomyocytes | 12 | 0.001364 |
| hsa04727 | GABAergic synapse | 9 | 0.001523 |
| hsa05030 | Cocaine addiction | 7 | 0.001541 |
| hsa04390 | Hippo signaling pathway | 12 | 0.001790 |
| hsa04725 | Cholinergic synapse | 10 | 0.002243 |
| hsa04724 | Glutamatergic synapse | 10 | 0.002693 |
| hsa05200 | Pathways in cancer | 21 | 0.002768 |
| hsa04923 | Regulation of lipolysis in adipocytes | 7 | 0.003081 |
| hsa05414 | Dilated cardiomyopathy | 8 | 0.005886 |
| hsa04911 | Insulin secretion | 8 | 0.006278 |
| hsa04921 | Oxytocin signaling pathway | 11 | 0.007747 |
| hsa04976 | Bile secretion | 7 | 0.008632 |
| hsa04520 | Adherens junction | 7 | 0.009886 |
Enriched by DAVID, p < 0.01